The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Established in 1989, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 12 countries and regions, including Algeria, Bahrain, Iraq, Jordan, Kuwait, Oman, Qatar, Saudi Arabia, Sudan, Switzerland, and the UAE . With a dedicated team of over 2,000 employees, it operates GMP-certified facilities producing a diverse range of products, including solids, liquids, cytotoxic drugs, and sterile injectables . As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

This CTD dossier owner and manufacturer boasts over 35 years of experience producing a wide range of pharmaceuticals. They operate across multiple facilities in Southeast Asia, with production lines focused on prescription medications, over-the-counter drugs, and dietary supplements. Key therapy areas include cardiovascular, diabetes, digestive health, respiratory conditions, and musculoskeletal disorders. Their product portfolio encompasses various dosage forms, including tablets, capsules, and liquids. The company holds GMP certifications and has registered several patents for their innovative products. They emphasize quality assurance and continuous innovation to meet the evolving needs of customers in regions such as North America and the EU.